1. Home
  2. EYPT vs SCHL Comparison

EYPT vs SCHL Comparison

Compare EYPT & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SCHL
  • Stock Information
  • Founded
  • EYPT 1987
  • SCHL 1920
  • Country
  • EYPT United States
  • SCHL United States
  • Employees
  • EYPT N/A
  • SCHL N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SCHL Books
  • Sector
  • EYPT Industrials
  • SCHL Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • EYPT 579.4M
  • SCHL 478.8M
  • IPO Year
  • EYPT 2005
  • SCHL 1987
  • Fundamental
  • Price
  • EYPT $9.65
  • SCHL $21.57
  • Analyst Decision
  • EYPT Strong Buy
  • SCHL
  • Analyst Count
  • EYPT 8
  • SCHL 0
  • Target Price
  • EYPT $24.75
  • SCHL N/A
  • AVG Volume (30 Days)
  • EYPT 841.7K
  • SCHL 288.2K
  • Earning Date
  • EYPT 08-06-2025
  • SCHL 07-17-2025
  • Dividend Yield
  • EYPT N/A
  • SCHL 3.81%
  • EPS Growth
  • EYPT N/A
  • SCHL N/A
  • EPS
  • EYPT N/A
  • SCHL 0.65
  • Revenue
  • EYPT $56,042,000.00
  • SCHL $1,592,100,000.00
  • Revenue This Year
  • EYPT N/A
  • SCHL $3.42
  • Revenue Next Year
  • EYPT N/A
  • SCHL $5.47
  • P/E Ratio
  • EYPT N/A
  • SCHL $32.18
  • Revenue Growth
  • EYPT 12.04
  • SCHL N/A
  • 52 Week Low
  • EYPT $3.91
  • SCHL $15.77
  • 52 Week High
  • EYPT $13.99
  • SCHL $38.77
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.83
  • SCHL 66.84
  • Support Level
  • EYPT $8.96
  • SCHL $20.89
  • Resistance Level
  • EYPT $10.77
  • SCHL $21.87
  • Average True Range (ATR)
  • EYPT 0.74
  • SCHL 0.86
  • MACD
  • EYPT -0.02
  • SCHL 0.18
  • Stochastic Oscillator
  • EYPT 60.25
  • SCHL 78.66

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: